ICI	Immune checkpoint inhibitor
TC	Paclitaxel plus carboplatin (Taxol–Carbo) chemotherapy
MMR	Mismatch repair
dMMR	Deficient mismatch repair
pMMR	Proficient mismatch repair
PFI	Platinum-free interval
TFI	Treatment-free interval
PFS	Progression-free survival
OS	Overall survival
DSPR	Duration of secondary platinum response
HR	Hazard ratio
GOG	Gynecologic Oncology Group
SGSG	Sankai Gynecologic Study Group
GOTIC	Gynecologic Oncology Trial and Investigation Consortium
NCCN	National Comprehensive Cancer Network
ESGO	European Society of Gynaecological Oncology
NSMP	No specific molecular profile
MSI-H	Microsatellite instability-high
LEN + PEM	Lenvatinib plus pembrolizumab